Loading...
•
Mar 31, 2025
Integra LifeSciences Q1 2025 Earnings Report
Integra LifeSciences reported financial results for the first quarter ending March 31, 2025.
Key Takeaways
Integra LifeSciences reported total revenues of $382.7 million in the first quarter of 2025, a 3.7% increase year-over-year. GAAP net loss was $(25.3) million, or $(0.33) per diluted share, while adjusted net income was $31.7 million, or $0.41 per diluted share. The company is reaffirming its full-year revenue guidance but updating adjusted EPS guidance due to new tariffs.
Total revenues increased 3.7% on a reported basis to $382.7 million.
GAAP net loss per diluted share was $(0.33), compared to $(0.04) in the prior year.
Adjusted earnings per diluted share were $0.41, compared to $0.55 in the prior year.
Full-year 2025 revenue guidance was reaffirmed, while adjusted EPS guidance was updated due to new tariffs.
Revenue by Segment
Forward Guidance
For the second quarter 2025, the Company expects reported revenues in the range of $390 million to $400 million and adjusted EPS in a range of $0.40 to $0.45 per share. For the full year 2025, the Company is reaffirming its revenue guidance ranges of $1.650 billion to $1.715 billion and reducing its adjusted EPS guidance to a range of $2.19 to $2.29 per share.
Positive Outlook
- Reaffirming full-year 2025 revenue guidance range.
- Expected sequential increase in revenue in the second quarter.
- Acclarent acquisition will be included in organic growth beginning in the second quarter of 2025.
- Advancing Compliance Master Plan and investments in supply reliability.
- Expansion of international portfolio.
Challenges Ahead
- Updating adjusted EPS guidance to account for the impact related to new tariffs.
- Expected reported and organic revenue decline in the second quarter compared to the prior year.
- Adjusted EPS guidance for the full year is reduced.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...